Researchers reveal why cancer and insulin resistance are a “really bad” combination

Print Friendly, PDF & Email

insulin-resistance(NaturalHealth365)  Cancer continues to pose a significant health challenge, with an estimated two million new diagnoses projected in the United States from the beginning of 2023 until the year’s end.  Tragically, over 600,000 Americans will succumb to the disease after receiving a cancer diagnosis during this period.  As researchers delve deeper into the complexities of cancer, its prevention, and treatment, new insights emerge.

In this context, a recent meta-analysis has shed light on the detrimental impact of the combination of cancer and insulin resistance on patient health outcomes.  Notably, individuals diagnosed with cancer often exhibit a higher incidence of insulin resistance, a finding that has captured the academic community’s interest.

Meta-analysis reveals alarming link between cancer and insulin resistance

Meta-analysis may sound complex, but it’s a straightforward method that involves a systematic review of multiple academic studies.  In the case mentioned earlier, this meta-analysis focused on examining cancer patients’ resistance to insulin.

To evaluate insulin resistance, researchers utilized a technique called the hyperinsulinemic-euglycemic clamp.  This method measures insulin secretion and subsequent resistance, providing valuable insights into a patient’s glucose metabolism and insulin sensitivity.  Insulin resistance plays a pivotal role in metabolic dysfunction, a condition commonly observed in individuals battling cancer.  Metabolic dysfunction is associated with increased cancer recurrence rates and shorter lifespans, making insulin resistance a concerning issue for cancer patients.

The analysis concentrated on cancer patients aged late teens and older, comparing them with age-matched control groups without cancer.  The researchers meticulously searched various medical databases, including the Cochrane Central Register of Controlled Trials, Embase, and Medline, to gather data for their analysis.

This study is particularly significant as it represents the first comprehensive compilation of research data, specifically exploring the differences in insulin resistance between cancer patients and the general population.  Moreover, as we delve into the details below, the findings have the potential to pave the way for improved health and extended lives for those diagnosed with this formidable disease.

How cancer patients battle a hidden enemy

The findings from the meta-analysis reveal a significant link between cancer diagnosis and insulin resistance.  Specifically, control subjects demonstrated a glucose disposal rate stimulated by insulin of 7.5 mg/kg/min, whereas cancer patients exhibited a significantly lower rate of 4.7 mg/kg/min.

The data presented above quantifies the higher level of insulin resistance observed in individuals diagnosed with cancer.  This metabolic dysfunction significantly increases the risk of cancer recurrence, ultimately jeopardizing survival rates.

These findings raise two critical questions that demand exploration.  Firstly, medical professionals are eager to understand the underlying reasons why cancer patients tend to exhibit greater insulin resistance.  Secondly, there is a pressing need to investigate whether proactively addressing a cancer patient’s insulin resistance can lead to positive health outcomes such as cancer remission and an extended lifespan.  By delving into these questions, the medical community seeks to unravel the mysteries surrounding insulin resistance in cancer patients and potentially pave the way for improved treatment strategies and patient outcomes.

Lifestyle choices as armor: Fortifying your defenses against cancer

While some cancer diagnoses are rooted in genetics, most are directly influenced or partially attributed to lifestyle choices.  By making conscious decisions, you can significantly reduce the risk of certain cancers and fortify your defenses.  Here are key lifestyle strategies to consider:

Exercise regularly: Regular physical activity can lower the risk of colon cancer plus many other forms of cancer.  Aim for a consistent exercise routine that suits your abilities and preferences.

Adopt a healthy diet:  Embrace a diet rich in organic, whole foods with lots of vegetables and fruits.  Minimize the consumption of highly processed foods and excess sugars.  Bottom line: strive for a balanced and nutritious eating plan to support optimal energy levels and overall well-being.

Moderate alcohol consumption:  If you consume alcohol, it is best to limit your intake to one drink per day.  This moderation can help reduce the risk of certain cancers.  If possible, avoid drinking alcohol and dramatically reduce your risk of inflammation and metabolic disorders.

Say no to tobacco:  Resist the temptation to indulge in tobacco in any form.  Avoiding tobacco products is crucial to protect yourself from the harmful effects of smoking and secondhand smoke.

Embrace vitamin C and D:  Ensure you receive adequate amounts of vitamin C and D.  For healthy individuals, many holistic doctors and health coaches will suggest taking between 6,000 and 10,000 mg. of vitamin C and at least 5,000 IU of vitamin D per day.  Depending on your health status, you may need more amounts per day to correct deficiencies.

So why not incorporate these common-sense lifestyle choices into your daily routine to bolster your defense against cancer and enhance your overall well-being?  After all, you’re worth it.

Editor’s note: To learn more about how to stop cancer naturally, own the Stop Cancer Docu-Class created by NaturalHealth365 Programs and featuring many of the top cancer experts in holistic healthcare.

Sources for this article include:

Notify of

1 Comment
Newest Most Voted
Inline Feedbacks
View all comments